Predictors of chronic kidney disease among HIV–infected patients on highly active antiretroviral therapy at the University of Calabar Teaching Hospital, Calabar, South-South Nigeria

References

• UNAIDS Report on the Global AIDS Epidemic 2013. UNAIDS; 2013 Available from: http://www.unaids.org/sites/default/files/en/media/unaids/contentassets/documents/epidemiology/2013/gr2013/UNAIDS_Global_Report_2013
   Google Scholar
• Szczech LA, Hoover DR, Feldman JG, et al. Association between renal disease and outcomes among HIV-infected women receiving or not receiving antiretroviral therapy. Clin Infect Dis. 2004;39(8):1199–1206. doi:10.1086/42401315486845
   PubMed Web of Science ®Google Scholar
• Schwartz EJ, Szczech LA, Ross MJ, Klotman ME, Winston JA, Klotman PE. Highly active antiretroviral therapy and the epidemic of HIV+ end-stage renal disease. J Am Soc Nephrol. 2005;16:2412–2420. doi:10.1681/ASN.200504034015987747
   PubMed Web of Science ®Google Scholar
• Eggers PW, Kimmel PL. Is there an epidemic of HIV infection in the US ESRD program? J Am Soc Nephrol. 2004;15:2477–2485. doi:10.1097/01.ASN.0000138546.53152.A715339998
   PubMed Web of Science ®Google Scholar
• Gupta SK, Eustace JA, Winston JA, et al. Guidelines for the management of chronic kidney disease in HIV infected patients: recommendations of the HIV Medicine Association of the Infectious Disease Society of America. Clin Infect Dis. 2005;40:1559–1585. doi:10.1086/43025715889353
   PubMed Web of Science ®Google Scholar
• Emem-Chioma P, Arogundade FA, Sanusi AA, Wokoma FS, Akinsola A. Renal disease in HIV-seropositive patients in Nigeria: an assessment of prevalence, clinical features and risk factors. Nephrol Dial Transplant. 2008;23:741–746. doi:10.1093/ndt/gfm83618065807
   PubMed Web of Science ®Google Scholar
• Agaba EI, Agaba PA, Sirisena ND, Anteyi EA, Idoko JA. Renal disease in the acquired immunodeficiency syndrome in North Central Nigeria. Niger J Med. 2003;12:120–125.14737980
   PubMedGoogle Scholar
• Anyabolu EN, Chukwuonye II, Arodiwe E, Ijoma CK, Ulasi I. Prevalence and predictors of chronic kidney disease in newly diagnosed human immunodeficiency virus patients in Owerri, Nigeria. Ind J Nephrol. 2016;26(1):10–15. doi:10.4103/0971-4065.156115
   Google Scholar
• Umeizudike T, Mabayoje M, Okany C, Abdulkareem F, Adeyomoye A, Okubadejo N. Okpechi prevalence of chronic kidney disease in HIV positive patients in Lagos, South-west Nigeria. Nephrol Rev. 2012;4:22–26. doi:10.4081/nr.2012.e5
   Google Scholar
• Lucas GM, Lau B, Atta MG, Fine DM, Keruly J, Moore RD. Chronic kidney disease incidence, and progression to end-stage renal disease, in HIV-infected individuals: a tale of two races. J Infect Dis. 2008;197(11):1548–1557. doi:10.1086/58799418422458
   PubMed Web of Science ®Google Scholar
• Szczech LA, Gupta SK, Habash R, et al. The clinical epidemiology and course of the spectrum of renal diseases associated with HIV infection. Kidney Int. 2004;66:1145–1152. doi:10.1111/j.1523-1755.2004.00865.x15327410
   PubMed Web of Science ®Google Scholar
• Gerntholtz TE, Goetsch SJ, Katz I. HIV-related nephropathy: a South African perspective. Kidney Int. 2006;69:1885–1891. doi:10.1038/sj.ki.500035116625149
   PubMed Web of Science ®Google Scholar
• Estrella M, Fine DM, Gallant JE, et al. HIV type 1 RNA level as a clinical indicator of renal pathology in HIV-infected patients. Clin Infect Dis. 2006;43:377–3380. doi:10.1086/50549716804855
   PubMed Web of Science ®Google Scholar
• Shahinian V, Rajaraman S, Borucki M, Grady J, Hollander WM, Ahuja TS. Prevalence of HIV-associated nephropathy in autopsies of HIV-infected patients. Am J Kidney Dis. 2000;35:884–888. doi:10.1016/S0272-6386(00)70259-910793023
   PubMed Web of Science ®Google Scholar
• D’Agati V, Suh JI, Carbone L, Cheng JT, Appel G. Pathology of HIV-associated nephropathy: a detailed morphologic and comparative study. Kidney Int. 1989;35:1358–1370. doi:10.1038/ki.1989.1352770114
   PubMed Web of Science ®Google Scholar
• Rao TK, Friedman EA, Nicastri AD. The types of renal disease in the acquired immunodeficiency syndrome. N Engl J Med. 1987;316:1062–1068. doi:10.1056/NEJM1987042331617053561458
   PubMed Web of Science ®Google Scholar
• Laradi A, Mallet A, Beaufils H, Allouache M, Martinez F. HIV-associated nephropathy: outcome and prognosis factors. Groupe d’ Etudes Nephrologiques d’Ile de France. J Am Soc Nephrol. 1998;9:2327–2335.9848787
   PubMed Web of Science ®Google Scholar
• US Renal Data System. USRDS 2007 Annual Data Report: Atlas of Chronic Kidney Disease and End-Stage Renal Disease in the United States. Bethesda (MD): National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases; 2007.
   Google Scholar
• Ahuja TS, Grady J, Khan S. Changing trends in the survival of dialysis patients with human immunodeficiency virus in the United States. J Am Soc Nephrol. 2002;13:1889–1893.12089385
   PubMed Web of Science ®Google Scholar
• Lucas GM, Eustace JA, Sozio S, Mentari EK, Appiah KA, Moore RD. Highly active antiretroviral therapy and the incidence of HIV-1-associated nephropathy: a 12-year cohort study. Aids. 2004;18:541–546.15090808
   PubMed Web of Science ®Google Scholar
• Winston J, Deray G, Hawkins T, Szczech L, Wyatt C, Young B. Kidney disease in patients with HIV infection and AIDS. Clin Infect Dis. 2008;47:1449–1457. doi:10.1086/59309918947327
   PubMed Web of Science ®Google Scholar
• Röling J, Schmid H, Fischereder M, Draenert R, Goebel F. HIV-associated renal diseases and highly active antiretroviral therapy-induced nephropathy. Clin Infect Dis. 2006;42:1488–1495. doi:10.1086/50356616619164
   PubMed Web of Science ®Google Scholar
• Ravasi G, Lauriola M, Tinelic C, Brandolini M, Uglietti A, Maserati R. Comparism of glomerulae filtration rate estimate vs. 24-h creatinine clearance in HIV-positive patients. HIV Med. 2009;10(4):219–228. doi:10.1111/j.1468-1293.2008.00673.x19187174
   PubMed Web of Science ®Google Scholar
• National Kidney Foundation. K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. Am J Kidney Dis. 2002;39:S1–S266.11904577
   PubMed Web of Science ®Google Scholar
• Adedeji TA, Adedeji ON, Adebisi SA, Idowu AA, Fawale MB, Jimoh KA. Prevalence and pattern of chronic kidney disease in antiretroviral-naive patients with HIV/AIDS. J Int Assoc Provid AIDS Care. 2015;14(5):434–440. doi:10.1177/232595741558757026013249
   PubMedGoogle Scholar
• Mocroft A, Kirk O, Gatell J, et al. Chronic renal failure among HIV-1-infected patients. Aids. 2007;21:1119–1127. doi:10.1097/QAD.0b013e3280f774ee17502722
   PubMed Web of Science ®Google Scholar
• Crum-Cianflone N, Ganesan A, Teneza-Mora N, et al. Prevalence and factors associated with renal dysfunction among HIV-infected patients. AIDS Patient Care STDS. 2010;24:353–360. doi:10.1089/apc.2009.032620515419
   PubMed Web of Science ®Google Scholar
• Overton ET, Nurutdinova D, Freeman J, Seyfried W, Mondy KE. Factors associated with renal dysfunction within an urban HIV-infected cohort in the era of highly active antiretroviral therapy. HIV Med. 2009;10:343–350. doi:10.1111/j.1468-1293.2009.00693.x19490182
   PubMed Web of Science ®Google Scholar
• Szczech LA, Gange SJ, van der Horst C, et al. Predictors of proteinuria and renal failure among women with HIV infection. Kidney Int. 2002;61:195–202. doi:10.1046/j.1523-1755.2002.00094.x11786101
   PubMed Web of Science ®Google Scholar
• Reid A, Stöhr W, Walker AS, et al. Severe renal dysfunction and risk factors associated with renal impairment in HIV-infected adults in Africa initiating antiretroviral therapy. Clin Infect Dis. 2008;46:1271–1281. doi:10.1086/53346818444867
   PubMed Web of Science ®Google Scholar
• Fux CA, Simcock M, Wolbers M, et al. Tenofovir use is associated with a reduction in calculated glomerular filtration rates in the Swiss HIV Cohort Study. Antivir Ther. 2007;12(8):1165–1173.18240857
   PubMed Web of Science ®Google Scholar
• Horberg M, Tang B, Towner W, et al. Impact of tenofovir on renal function in HIV-infected, antiretroviral-naive patients. J Acquir Immune Defic Syndr. 2010;53(1):62–69. doi:10.1097/QAI.0b013e3181be6be219838127
   PubMed Web of Science ®Google Scholar
• Laprise C, Baril J-G, Dufresne S, Trottier H. Association between tenofovir exposure and reduced kidney function in a cohort of HIV-positive patients: results from 10 years of follow-up. Clin Infect Dis. 2013;56(4):567–575. doi:10.1093/cid/cis93723143096
   PubMed Web of Science ®Google Scholar
• Brennan A, Evans D, Maskew M, et al. Relationship between renal dysfunction, nephrotoxicity and death among HIV adults on tenofovir. Aids. 2011;25(13):1603–1609. doi:10.1097/QAD.0b013e328343443b21646902
   PubMed Web of Science ®Google Scholar
• Mulenga L, Musonda P, Mwango A, et al. Effect of baseline renal function on tenofovir-containing antiretroviral therapy outcomes in Zambia. Clin Infect Dis. 2014;58(10):1473–1480. doi:10.1093/cid/ciu11724585558
   PubMed Web of Science ®Google Scholar
• Shemesh O, Golbetz H, Kriss JP, Myers BD. Limitations of creatinine as a filtration marker in glomerulopathic patients. Kidney Int. 1985;28:830–838. doi:10.1038/ki.1985.2052418254
   PubMed Web of Science ®Google Scholar
• Agbaji OO, Onu A, Agaba PE, Muazu MA, Falang KD, Idoko JA. Predictors of impaired renal function among HIV infected patients commencing highly active antiretroviral therapy in Jos, Nigeria. Niger Med J. 2011;52:182–185.22083208
   PubMedGoogle Scholar
• Cheung CY, Wong KM, Lee MP, et al. Prevalence of chronic kidney disease in Chinese HIV-infected patients. Nephrol Dial Transplant. 2007;22:3186–3190. doi:10.1093/ndt/gfm35017575315
   PubMed Web of Science ®Google Scholar